In the 8th edition of the TNM classification, the determination of extranodal tumour growth (ENE, extranodal extension) was excluded in pretherapeutic staging for HPV16/p16-positive oropharyngeal carcinomas, but it remains highly valid for postoperative adjuvant therapy decisions. This evidence concerns the gene CDKN2A and neoplasm.